GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...

EST: Adds comments from CSL The U.S. has reportedly awarded $72M to GSK (NYSE:GSK), Sanofi (NASDAQ:SNY), and CSL (OTCQX:CSLLY ...

GSK’s ex-head of vaccines says its blockbuster jab for a flu-like virus that spreads in the autumn and winter is too ...

There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...

The U.S. government collaborates with GSK, Sanofi, and CSL to enhance bird flu vaccine production. This initiative aims to ...

GSK’s peers in the race to get the first mRNA flu vaccine to market have all encountered the same problem when it comes to B strains. Moderna is the only competitor to have already secured full ...

Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...

US has announced team up with multinational pharmaceutical companies CSL, GSK, Sanofi, and Seqirus for a $72 million worth of ...

The U.S. government has allocated $72 million to GSK, Sanofi, and CSL Ltd to enhance bird flu vaccine production amid a ...

As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...

GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, ...